[Changes in antitoxic and prothrombin- and bilirubin-producing functions of the liver in patients with chronic myelosis treated with myelosan (Myleran)].
GORELOV
I Z
IZ
LIPKOVICH
B I
BI
D001663:Bilirubin; D002066:Busulfan / Q000628:therapy*; D007938:Leukemia; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D007951:Leukemia, Myeloid / Q000628:therapy*; D008099:Liver / Q000494:pharmacology*; D011516:Prothrombin
D011516:Prothrombin; D002066:Busulfan; D001663:Bilirubin
BILIRUBIN; BUSULFAN/therapy; LEUKEMIA, MYELOCYTIC/therapy; LIVER/pharmacology; PROTHROMBIN